CUNEO, ANTONIO
 Distribuzione geografica
Continente #
NA - Nord America 195
EU - Europa 150
AS - Asia 107
AF - Africa 2
Totale 454
Nazione #
US - Stati Uniti d'America 193
CN - Cina 64
IE - Irlanda 49
IT - Italia 43
SG - Singapore 39
SE - Svezia 17
FI - Finlandia 13
DE - Germania 12
TR - Turchia 4
UA - Ucraina 4
AT - Austria 3
FR - Francia 3
CA - Canada 2
CH - Svizzera 2
GB - Regno Unito 2
CI - Costa d'Avorio 1
CZ - Repubblica Ceca 1
SC - Seychelles 1
SI - Slovenia 1
Totale 454
Città #
Dublin 49
Singapore 32
Chandler 27
Parma 18
Ashburn 16
Shanghai 15
Boardman 13
Dearborn 13
Jacksonville 10
Nanjing 8
Princeton 8
Beijing 7
San Mateo 7
Jinan 6
Milan 6
Nanchang 6
Ann Arbor 5
Helsinki 5
Saint Louis 5
Wilmington 5
Izmir 4
Bologna 3
Marseille 3
Munich 3
Redwood City 3
Seattle 3
Vienna 3
Des Moines 2
Guangzhou 2
Hebei 2
Jiaxing 2
Lausanne 2
New York 2
Pescara 2
Sassuolo 2
Shenyang 2
Toronto 2
Zhengzhou 2
Abidjan 1
Boretto 1
Bremen 1
Brno 1
Chicago 1
Dallas 1
Düsseldorf 1
Fairfield 1
Falls Church 1
Fremont 1
Genoa 1
Grafing 1
Hangzhou 1
Hefei 1
Houston 1
Los Angeles 1
Magdeburg 1
Tianjin 1
Viterbo 1
Washington 1
Woodbridge 1
Totale 326
Nome #
Etiology of febrile episodes in patients with acute myeloid leukemia: results from the Hema e-Chart Registry 64
A prospective survey of febrile events in hematological malignancies 62
Hema e-Chart: Italian Registry for prospective analysis of epidemiology, management and outcome of febrile events in patients with hematological malignancies. 57
Orthogonal Proteogenomic Approaches Identify the Druggable PA2G4-MYC Axis in 3q26 AML 54
THERAPEUTIC TARGETING OF NOTCH SIGNALING PATHWAY IN HEMATOLOGICAL MALIGNANCIES 49
Epidemiology, outcome, and risk factors for infectious complications in myelofibrosis patients receiving ruxolitinib: A multicenter study on 446 patients 47
Baseline factors associated with response to ruxolitinib: An independent study on 408 patients with myelofibrosis 42
A new NDE1/PDGFRB fusion transcript underlying chronic myelomonocytic leukaemia in Noonan Syndrome 41
Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study 26
Secondary infections worsen the outcome of COVID-19 in patients with hematological malignancies: A report from the ITA-HEMA-COV 20
Orthogonal proteogenomic analysis identifies the druggable PA2G4-MYC axis in 3q26 AML 9
Totale 471
Categoria #
all - tutte 2.532
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.532


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202049 0 0 0 0 8 13 9 3 6 3 5 2
2020/202129 0 2 3 1 11 1 0 0 8 0 3 0
2021/202236 0 0 0 0 1 1 3 6 1 6 5 13
2022/2023129 12 4 6 3 15 9 1 10 60 0 6 3
2023/2024110 6 8 2 2 4 14 24 6 9 12 8 15
2024/202569 7 13 19 24 6 0 0 0 0 0 0 0
Totale 471